Timing Pharmaceutical Co

Timing Pharmaceutical Co Current Ratio

The Current Ratio of Timing Pharmaceutical Co (6659.TWO) as of Nov 2, 2026 is 1.19. In the previous year, Current Ratio was 1.09 — a change of 8.26% (higher).

Current Ratio

1.19

YoY

8.26%

Last updated:

Current Ratio of Timing Pharmaceutical Co is 2024 1.19 . Current Ratio of Timing Pharmaceutical Co was 2023 1.09 . It decreases by 8.26% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co Ltd generates revenue through manufacturing concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations for domestic and overseas markets. The company accepts applications for licenses and permits related to Chinese medicine, food, and pharmaceutical products, and offers contract manufacturing services. Its comprehensive sales network covers Chinese medicine hospitals and major pharmacies across Taiwan, supported by a professional supply chain and service network. The firm also provides testing services and CDMO services for new pilot projects in research and development. The primary buyers of Timing Pharmaceutical's products include Chinese medicine hospitals, major pharmacies, and overseas markets. Domestic sales are facilitated through a full-fledged professional supply chain and service network, while overseas markets are served through direct exports and partnerships. The company's focus on traditional Chinese medicine and pharmaceuticals drives demand from healthcare institutions and consumers seeking natural health solutions. Timing Pharmaceutical Co Ltd invests annually in research and development for new pilot projects, which are supported by its contract research and development and manufacturing organization (CDMO) services. These services are contracted by clients seeking to develop and manufacture pharmaceutical products, including traditional Chinese medicine formulations. The company's portfolio includes concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations, all of which are distributed through its established network. Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

Current Ratio of Timing Pharmaceutical Co is 1.19 in 2024.

Current Ratio of Timing Pharmaceutical Co changed from 1.09 to 1.19, representing a 8.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Timing Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Timing Pharmaceutical Co

All Key Metrics — Timing Pharmaceutical Co